- Joined
- May 13, 2010
- Messages
- 190
- Reaction score
- 5
I understand the benefits of a cardioselective beta-blocker over a nonselective beta-blocker in pt's with asthma, diabetes and peripheral vascular disease, but what the heck are the benefits of using a nonselective over cardioselective? Why use nonselective beta blockers like propanolol and timolol over others? Are they more efficacious or something? Cheaper for patients?
In the case of timolol for decreasing aqueous production, a quick pubmed search led some abstracts to pop up that mentioned that Betaxolol, which is cardioselective, is able to decrease IOP almost as much as Timolol, may actually result in greater visual field preservation despite the slightly smaller decrease in IOP-reduction that you'd see in Timolol (probably through some other neuroprotective mechanisms), has less systemic circulation compared to Timolol, and is devoid of the bronchopulmonary/cardiac effects you'd see with a nonselective drug like Timolol.
Soooo, why choose drugs like Timolol and Propanolol??
In the case of timolol for decreasing aqueous production, a quick pubmed search led some abstracts to pop up that mentioned that Betaxolol, which is cardioselective, is able to decrease IOP almost as much as Timolol, may actually result in greater visual field preservation despite the slightly smaller decrease in IOP-reduction that you'd see in Timolol (probably through some other neuroprotective mechanisms), has less systemic circulation compared to Timolol, and is devoid of the bronchopulmonary/cardiac effects you'd see with a nonselective drug like Timolol.
Soooo, why choose drugs like Timolol and Propanolol??